1-2 of 2
Asuscena L. Beltran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL

Karamjeet S. Sandhu, Alan Macias, Marissa Del Real, Asuscena L. Beltran, Young Sun Kim, Jianying Zhang, Joycelynne Palmer, Marjorie Robbins, Reyna Loomis, Mojtaba Akhtari, Ahmed Aribi, Shukaib Arslan, Amandeep Salhotra, Matthew Mei, Hoda Pourhassan, Paul B. Koller, Idoroenyi Amanam, Vaibhav Agrawal, Peter T. Curtin, Ricardo Spielberger, Vinod A. Pullarkat, Ibrahim Aldoss, F. Mark Stewart, Eileen P. Smith, Stephen J Forman, Anthony S. Stein, Guido Marcucci, L. Elizabeth Budde
Journal: Blood
Blood (2022) 140 (Supplement 1): 8985–8986.
https://doi.org/10.1182/blood-2022-170279
Published: 2022
Journal Articles

Promising Safety and Efficacy Results from an Ongoing Phase 1b Study of Pembrolizumab Combined with Decitabine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Vaibhav Agrawal, Cindy Croslin, Asuscena L. Beltran, Jianying Zhang, Joycelynne Palmer, Quy Huynh-Tran, Rochelle Hernandez, Sandra Thomas, Marjorie Robbins, Ahmed Aribi, Haris Ali, Anthony S. Stein, Elizabeth L. Budde, Monzr M. Al Malki, Guido Marcucci
Journal: Blood
Blood (2022) 140 (Supplement 1): 6235–6236.
https://doi.org/10.1182/blood-2022-165894
Published: 2022